Contribution of screening and survival differences to racial disparities in colorectal cancer rates

Cancer Epidemiology Biomarkers and Prevention

Volumn 21, Issue 5, 2012, Pages 728-736

  Lansdorp Vogelaar, Iris ^a   Kuntz, Karen M ^b   Knudsen, Amy B ^c   Van Ballegooijen, Marjolein ^a   Zauber, Ann G ^d   Jemal, Ahmedin ^e  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF MINNESOTA   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^e AMERICAN CANCER SOCIETY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AFRICAN AMERICAN; ARTICLE; CANCER INCIDENCE; CANCER MORTALITY; CANCER SCREENING; CANCER SURVIVAL; COLORECTAL CANCER; EUROPEAN AMERICAN; FEMALE; HEALTH CARE ACCESS; HUMAN; MALE; PRIORITY JOURNAL; RACE DIFFERENCE;

AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; EARLY DETECTION OF CANCER; EUROPEAN CONTINENTAL ANCESTRY GROUP; HEALTH STATUS DISPARITIES; HUMANS; INCIDENCE; MASS SCREENING; MIDDLE AGED; SURVIVAL RATE;

EID: 84862896363     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-12-0023     Document Type: Article

References (62)

1. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin 2010;60:277-300.
2. American Cancer Society. Colorectal cancer facts & figures 2008-2010. Atlanta, GA: American Cancer Society; 2008.
3. DeLancey JO, Thun MJ, Jemal A, Ward EM. Recent trends in Black-White disparities in cancer mortality. Cancer Epidemiol Biomarkers Prev 2008;17:2908-12.
4. Edwards BK, Ward E, Kohler BA, Eheman C, Zauber AG, Anderson RN, et al. Annual report to the nation on the status of cancer, 1975-2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates. Cancer 2010;116:544-73.
5. Screening for colorectal cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2008;149:627-37.
6. Levin B, Lieberman DA, McFarland B, Smith RA, Brooks D, Andrews KS, et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. CA Cancer J Clin 2008;58:130-60. (Pubitemid 351830299)
7. Klabunde CN, Cronin KA, Breen N, Waldron WR, Ambs AH, Nadel MR. Trends in colorectal cancer test use among vulnerable populations in the United States. Cancer Epidemiol Biomarkers Prev 2011;20: 1611-21.
8. Berry J, Bumpers K, Ogunlade V, Glover R, Davis S, Counts-Spriggs M, et al. Examining racial disparities in colorectal cancer care. J Psychosoc Oncol 2009;27:59-83.
9. Hao Y, Landrine H, Jemal A, Ward KC, Bayakly AR, Young JL Jr., et al. Race, neighbourhood characteristics and disparities in chemotherapy for colorectal cancer. J Epidemiol Community Health 2011;65:211-7.
10. Obeidat NA, Pradel FG, Zuckerman IH, Trovato JA, Palumbo FB, DeLisle S, et al. Racial/ethnic and age disparities in chemotherapy selection for colorectal cancer. Am J Manag Care 2010;16:515-22.
11. Dignam JJ, Ye Y, Colangelo L, Smith R, Mamounas EP, Wieand HS, et al. Prognosis after rectal cancer in blacks and whites participating in adjuvant therapy randomized trials. J Clin Oncol 2003;21:413-20. (Pubitemid 46606468)
12. Albain KS, Unger JM, Crowley JJ, Coltman CA Jr., Hershman DL. Racial disparities in cancer survival among randomized clinical trials patients of the Southwest Oncology Group. J Natl Cancer Inst 2009;101:984-92.
13. Alexander DD, Waterbor J, Hughes T, Funkhouser E, Grizzle W, Manne U. African-American and Caucasian disparities in colorectal cancer mortality and survival by data source: an epidemiologic review. Cancer Biomark 2007;3:301-13. (Pubitemid 350187032)
14. Soneji S, Iyer SS, Armstrong K, Asch DA. Racial disparities in stage-specific colorectal cancer mortality: 1960-2005. Am J Public Health 2010;100:1912-6.
15. White A, Vernon SW, Franzini L, Du XL. Racial disparities in colorectal cancer survival: to what extent are racial disparities explained by differences in treatment, tumor characteristics, or hospital characteristics? Cancer 2010;116:4622-31.
16. Wei EK, Giovannucci E, Wu K, Rosner B, Fuchs CS, Willett WC, et al. Comparison of risk factors for colon and rectal cancer. Int J Cancer 2004;108:433-42. (Pubitemid 37549610)
17. Loeve F, Boer R, van Oortmarssen GJ, van Ballegooijen M, Habbema JD. The MISCAN-COLON simulation model for the evaluation of colorectal cancer screening. Comput Biomed Res 1999;32:13-33. (Pubitemid 29102594)
18. Loeve F, Brown ML, Boer R, van Ballegooijen M, van Oortmarssen GJ, Habbema JD. Endoscopic colorectal cancer screening: a cost-saving analysis [see comments]. J Natl Cancer Inst 2000;92:557-63. (Pubitemid 30212317)
19. Arminski TC, McLean DW. Incidence and distribution of adenomatous polyps of the colon and rectum based on 1,000 autopsy examinations. Dis Colon Rectum 1964;7:249-61.
20. Blatt L. Polyps of the colon and rectum: incidence and distribution. Dis Colon Rectum 1961;4:277-82.
21. Bombi JA. Polyps of the colon in Barcelona, Spain. An autopsy study. Cancer 1988;61:1472-6. (Pubitemid 18076428)
22. Chapman I. Adenomatous polypi of large intestine: incidence and distribution. Ann Surg 1963;157:223-6.
23. Clark JC, Collan Y, Eide TJ, Esteve J, Ewen S, Gibbs NM, et al. Prevalence of polyps in an autopsy series from areas with varying incidence of large-bowel cancer. Int J Cancer 1985;36:179-86. (Pubitemid 15243443)
24. Eide TJ. Risk of colorectal cancer in adenoma-bearing individuals within a defined population. Int J Cancer 1986;38:173-6. (Pubitemid 16043592)
25. Jass JR, Young PJ, Robinson EM. Predictors of presence, multiplicity, size and dysplasia of colorectal adenomas. A necropsy study in New Zealand. Gut 1992;33:1508-14.
26. Johannsen LG,Momsen O, Jacobsen NO. Polyps of the large intestine in Aarhus, Denmark. An autopsy study. Scand J Gastroenterol 1989;24:799-806. (Pubitemid 19226933)
27. Rickert RR, Auerbach O, Garfinkel L, Hammond EC, Frasca JM. Adenomatous lesions of the large bowel: an autopsy survey. Cancer 1979;43:1847-57. (Pubitemid 9203736)
28. Vatn MH, Stalsberg H. The prevalence of polyps of the large intestine in Oslo: an autopsy study. Cancer 1982;49:819-25. (Pubitemid 12165443)
29. Williams AR, Balasooriya BA, Day DW. Polyps and cancer of the large bowel: a necropsy study in Liverpool. Gut 1982;23:835-42. (Pubitemid 12018511)
30. Surveillance Epidemiology and End Results (SEER) Program. SEER*-Stat Database: Incidence - SEER 9 Regs Public Use. Nov 2003 Sub (1973-2001), DCCPS, Surveillance Research Program, Cancer Statistics Branch. Based on the November 2003 submission. Bethesda, MD: National Cancer Institute; 2004. [cited 2004 Apr]. Available from: www.seer.cancer.gov.
31. National Health Interview Survey: Centers for Disease Control and Prevention, National Center for Health Statistics. Available from: www.cdc.gov/nchs/nhis.htm.
32. Zauber A, Lansdorp-Vogelaar I, Wilschut J, Knudsen AB, van Ballegooijen M, KuntzKM.Cost-effectiveness ofDNAstool testing toscreen for colorectal cancer: report to AHRQ and CMS from the Cancer Intervention and Surveillance Modeling Network (CISNET) for MISCAN and SimCRC Models; 2007. Available from: http://www.cms.gov/medicare-coverage-database/details/technology- assessmentsdetails.aspx?TAId=52
33. Adam, Ali, Shorthouse. How accurate is the endoscopist's assessment of visualization of the left colon seen at flexible sigmoidoscopy? Colorectal Disease 2000;2:41-4.
34. Doria-Rose VP, Levin TR, Selby JV, Newcomb PA, Richert-Boe KE, Weiss NS. The incidence of colorectal cancer following a negative screening sigmoidoscopy: implications for screening interval. Gastroenterology 2004;127:714-22. (Pubitemid 39208404)
35. Loeve F, Boer R, van Ballegooijen M, van Oortmarssen GJ, Habbema JDF. Final report MISCAN-COLON microsimulation model for colorectal cancer: report to the National Cancer Institute Project No. NO1-CN55186. Rotterdam: Department of Public Health, Erasmus University; 1998.
36. Loeve F, Boer R, Zauber AG, Van Ballegooijen M, Van Oortmarssen GJ, Winawer SJ, et al. National Polyp Study data: evidence for regression of adenomas. Int J Cancer 2004;111:633-9. (Pubitemid 39045333)
37. Vogelaar I, van Ballegooijen M, Schrag D, Boer R, Winawer SJ, Habbema JD, et al. How much can current interventions reduce colorectal cancer mortality in the U.S.? Mortality projections for scenarios of risk-factor modification, screening, and treatment. Cancer 2006;107:1624-33. (Pubitemid 44546924)
38. American Cancer Society. Colorectal cancer facts & figures 2011-2013. Atlanta, GA: American Cancer Society; 2011.
39. Harper S, Lynch J.Methods formeasuring cancer disparities: usingdata relevant to healthy people 2010 cancer-related objectives. Bethesda, MD: National Cancer Institute; 2005. NIH Publication No. 05-5777.
40. Klabunde C, Brown M, Ballard-Barbash R, White MC, Thompson T, Plescia M, et al. Cancer Screening-United States, 2010. MMWR Morb Mortal Wkly Rep 2012;61:41-5.
41. Dimou A, Syrigos KN, Saif MW. Disparities in colorectal cancer in African-Americans vs. Whites: before and after diagnosis. World J Gastroenterol 2009;15:3734-43.
42. Laiyemo AO, Doubeni C, Pinsky PF, Doria-Rose VP, Bresalier R, Lamerato LE, et al. Race and colorectal cancer disparities: health-care utilization vs different cancer susceptibilities. J Natl Cancer Inst 2010;102:538-46.
43. Atkin W, Rogers P, Cardwell C, Cook C, Cuzick J, Wardle J, et al. Wide variation in adenoma detection rates at screening flexible sigmoidoscopy. Gastroenterology 2004;126:1247-56. (Pubitemid 38552789)
44. Bretagne JF, Hamonic S, Piette C, Manfredi S, Leray E, Durand G, et al. Variations between endoscopists in rates of detection of colorectal neoplasia and their impact on a regional screening program based on colonoscopy after fecal occult blood testing. Gastrointest Endosc 2010;71:335-41.
45. Bretthauer M, Skovlund E, Grotmol T, Thiis-Evensen E, Gondal G, Huppertz-Hauss G, et al. Inter-endoscopist variation in polyp and neoplasia pick-up rates in flexible sigmoidoscopy screening for colorectal cancer. Scand J Gastroenterol 2003;38:1268-74. (Pubitemid 38096086)
46. Imperiale TF, Glowinski EA, Juliar BE, Azzouz F, Ransohoff DF. Variation in polyp detection rates at screening colonoscopy. Gastrointest Endosc 2009;69:1288-95.
47. Kaminski MF, Regula J, Kraszewska E, Polkowski M, Wojciechowska U, Didkowska J, et al. Quality indicators for colonoscopy and the risk of interval cancer. N Engl J Med 2010;362:1795-803.
48. Bach PB, Pham HH, Schrag D, Tate RC, Hargraves JL. Primary care physicians who treat blacks and whites. N Engl J Med 2004;351: 575-84. (Pubitemid 39028925)
49. Huxley RR, Ansary-Moghaddam A, Clifton P, Czernichow S, Parr CL, Woodward M. The impact of dietary and lifestyle risk factors on risk of colorectal cancer: a quantitative overview of the epidemiological evidence. Int J Cancer 2009;125:171-80.
50. Cancer trends progress report. Bethesda, MD: National Cancer Institute, NIH, DHHS; 2010.
51. Hardcastle JD, Chamberlain JO, Robinson MH, Moss SM, Amar SS, Balfour TW, et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 1996;348:1472-7. (Pubitemid 26400242)
52. Kronborg O, Fenger C, Olsen J, Jorgensen OD, Sondergaard O. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet 1996;348:1467-71. (Pubitemid 26400241)
53. Mandel JS, Church TR, Ederer F, Bond JH. Colorectal cancer mortality: effectiveness of biennial screening for fecal occult blood. J Natl Cancer Inst 1999;91:434-7. (Pubitemid 29128279)
54. Bach PB, Schrag D, Brawley OW, Galaznik A, Yakren S, Begg CB. Survival of blacks and whites after a cancer diagnosis. JAMA 2002;287:2106-13. (Pubitemid 34437345)
55. Steinwachs D, Allen JD, Barlow WE, Duncan RP, Egede LE, Friedman LS, et al. National Institutes of Health state-of-the-science conference statement: Enhancing use and quality of colorectal cancer screening. Ann Intern Med 2010;152:663-7.
56. U.S. Department of Health & Human Services. The Health Care Law & You. 2012. Available from: http://www.healthcare.gov/law/introduction/index. html.
57. Hassan MO, Arthurs Z, Sohn VY, Steele SR. Race does not impact colorectal cancer treatment or outcomes with equal access.AmJ Surg 2009;197:485-90.
58. Hofmann LJ, Lee S, Waddell B, Davis KG. Effect of race on colon cancer treatment and outcomes in the Department of Defense healthcare system. Dis Colon Rectum 2010;53:9-15.
59. Berry J, Caplan L, Davis S, Minor P, Counts-Spriggs M, Glover R, et al. A black-white comparison of the quality of stage-specific colon cancer treatment. Cancer 2010;116:713-22.
60. Sanoff HK, Sargent DJ, Green EM, McLeod HL, Goldberg RM. Racial differences in advanced colorectal cancer outcomes and pharmaco-genetics: a subgroup analysis of a large randomized clinical trial. J Clin Oncol 2009;27:4109-15.
61. DuBardCA,YowA, Bostrom S, Attiah E, Griffith B, Lawrence W. Racial/ethnic differences in quality of care for North Carolina Medicaid recipients. N C Med J 2009;70:96-101.
62. Shih YC, Zhao L, Elting LS. Does Medicare coverage of colonoscopy reduce racial/ethnic disparities in cancer screening among the elderly? Health Aff (Millwood) 2006;25:1153-62. (Pubitemid 44188251)